Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.18B |
| 2 |
Microsoft
MSFT
|
+$1.11B |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$491M |
| 4 |
Technology Select Sector SPDR Fund
XLK
|
+$464M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$442M |
Top Sells
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.2B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$779M |
| 3 |
DuPont de Nemours
DD
|
+$443M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$359M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| 1 | Technology | 22.43% |
| 2 | Financials | 13.7% |
| 3 | Consumer Discretionary | 10.25% |
| 4 | Communication Services | 9.85% |
| 5 | Healthcare | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELME
1326
Elme Communities
ELME
$1.51B
| $4.1M | ﹤0.01% |
185,328
+71,533
| +63% | +$1.58M |
|
1327
First Financial Bancorp
FFBC
$2.46B
| $4.09M | ﹤0.01% |
170,637
+54,426
| +47% | +$1.31M |
|
1328
MGIC Investment
MTG
$6.55B
| $4.09M | ﹤0.01% |
295,220
+21,817
| +8% | +$302K |
|
1329
Frontdoor
FTDR
$4.83B
| $4.07M | ﹤0.01% |
75,712
+13,076
| +21% | +$703K |
|
1330
Stepan Co
SCL
$1.09B
| $4.07M | ﹤0.01% |
31,980
+488
| +2% | +$62K |
|
|
AEL
1331
DELISTED
American Equity Investment Life Holding Company
AEL
| $4.06M | ﹤0.01% |
128,929
+27,368
| +27% | +$863K |
|
|
TPTX
1332
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.06M | ﹤0.01% |
42,888
+29,163
| +212% | +$2.76M |
|
|
DCPH
1333
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.05M | ﹤0.01% |
90,367
+37,057
| +70% | +$1.66M |
|
1334
Quaker Houghton
KWR
$2.46B
| $4.04M | ﹤0.01% |
16,580
+1,547
| +10% | +$377K |
|
1335
SLM Corp
SLM
$5.86B
| $4.04M | ﹤0.01% |
224,524
+57,423
| +34% | +$1.03M |
|
1336
Live Oak Bancshares
LOB
$1.67B
| $4.03M | ﹤0.01% |
58,913
+49,766
| +544% | +$3.41M |
|
1337
Genpact
G
$7.41B
| $4.02M | ﹤0.01% |
93,937
+57,079
| +155% | +$2.44M |
|
|
XENT
1338
DELISTED
Intersect ENT, Inc
XENT
| $4.02M | ﹤0.01% |
192,705
+93,037
| +93% | +$1.94M |
|
1339
CVR Energy
CVI
$3.13B
| $4.02M | ﹤0.01% |
209,420
+131,138
| +168% | +$2.52M |
|
1340
Sarepta Therapeutics
SRPT
$1.82B
| $4.02M | ﹤0.01% |
53,886
+223
| +0.4% | +$16.6K |
|
1341
Sunstone Hotel Investors
SHO
$1.85B
| $4.01M | ﹤0.01% |
321,825
+206,675
| +179% | +$2.58M |
|
1342
First Trust Value Line Dividend Fund
FVD
$9.13B
| $4.01M | ﹤0.01% |
+105,483
| New | +$4.01M |
|
1343
Range Resources
RRC
$8.41B
| $4M | ﹤0.01% |
387,051
-49,521
| -11% | -$512K |
|
1344
Credit Acceptance
CACC
$5.33B
| $3.99M | ﹤0.01% |
11,088
-14,692
| -57% | -$5.29M |
|
1345
Boston Beer
SAM
$2.36B
| $3.99M | ﹤0.01% |
3,311
-981
| -23% | -$1.18M |
|
1346
Medpace
MEDP
$13.8B
| $3.99M | ﹤0.01% |
24,329
-16,679
| -41% | -$2.74M |
|
|
SASR
1347
DELISTED
Sandy Spring Bancorp Inc
SASR
| $3.97M | ﹤0.01% |
91,513
+22,212
| +32% | +$965K |
|
|
AAT
1348
American Assets Trust
AAT
$1.27B
| $3.96M | ﹤0.01% |
122,141
+19,890
| +19% | +$645K |
|
1349
Apellis Pharmaceuticals
APLS
$3.14B
| $3.95M | ﹤0.01% |
92,034
+3,404
| +4% | +$146K |
|
1350
Cannae Holdings
CNNE
$1.11B
| $3.95M | ﹤0.01% |
99,682
+3,167
| +3% | +$125K |
|